Stocks Under ₹100: Sumeet Bagadia Recommends 3 Shares to Buy on Monday

Stocks Under ₹100: Sumeet Bagadia Recommends 3 Shares to Buy on Monday, August 17, 2026

Summary

Indian equities ended the week on a weak note amid elevated crude oil prices, geopolitical concerns and mixed global cues. The Sensex fell 0.62% to 78,009.25, while the Nifty 50 declined 0.83% to 24,366. Against this backdrop, Sumeet Bagadia, Executive Director at Choice Broking, sees the Nifty maintaining a sideways bias and has recommended three stocks priced below ₹100 for Monday, August 17.

Sumeet Bagadia's 3 Stocks Under ₹100

• U. Y. Fincorp
  • Buy price: ₹21.08
  • Target price: ₹22.70
  • Stop loss: ₹20.00
  • Potential upside to target: ~7.7%
• Morepen Laboratories
  • Buy price: ₹84.19
  • Target price: ₹91.50
  • Stop loss: ₹78.50
  • Potential upside to target: ~8.7%
• Fineotex Chemical
  • Buy price: ₹43.36
  • Target price: ₹47.30
  • Stop loss: ₹40.78
  • Potential upside to target: ~9.1%

These are Bagadia's technical trading recommendations for the current market setup, not guaranteed returns.

Nifty 50 Outlook for Monday

Bagadia expects the Nifty to remain range-bound until a decisive breakout. He identified 24,200–24,250 as immediate support and 24,500–24,550 as key resistance. A sustained move above resistance could improve buying momentum, while a break below support could increase selling pressure. His expected trading range for the next session is 24,200–24,550.

Key Highlights

• U. Y. Fincorp: Target ₹22.70; stop loss ₹20.
• Morepen Laboratories: Target ₹91.50; stop loss ₹78.50.
• Fineotex Chemical: Target ₹47.30; stop loss ₹40.78.
• All three recommendations are under ₹100 based on the cited buy levels.
• Nifty support: 24,200–24,250.
• Nifty resistance: 24,500–24,550.
• Geopolitical uncertainty and elevated crude prices remain important risks for Indian equities.
• These recommendations are based on technical analysis and should be considered alongside one's own risk tolerance and investment horizon.

Disclaimer: The recommendations are attributed to Sumeet Bagadia/Choice Broking and are provided for educational and informational purposes. They are not personal investment advice. Investors should consult a SEBI-registered investment adviser before making investment decisions.